IN192180B - - Google Patents

Info

Publication number
IN192180B
IN192180B IN1002DE2001A IN192180B IN 192180 B IN192180 B IN 192180B IN 1002DE2001 A IN1002DE2001 A IN 1002DE2001A IN 192180 B IN192180 B IN 192180B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Deepak Murpani
Ashish Madan
Vinod Kumar Arora
Rajiv Malik
Original Assignee
Ranbaxy Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab filed Critical Ranbaxy Lab
Priority to IN1002DE2001 priority Critical patent/IN192180B/en
Priority to MXPA04002910A priority patent/MXPA04002910A/es
Priority to US10/432,654 priority patent/US20040059001A1/en
Priority to JP2003532037A priority patent/JP2005507896A/ja
Priority to EA200400487A priority patent/EA200400487A1/ru
Priority to EP02800214A priority patent/EP1434568A1/en
Priority to CNA02822180XA priority patent/CN1582145A/zh
Priority to BR0212931-0A priority patent/BR0212931A/pt
Priority to KR10-2004-7004586A priority patent/KR20040063900A/ko
Priority to PCT/IB2002/003997 priority patent/WO2003028704A1/en
Priority to ARP020103687A priority patent/AR037326A1/es
Publication of IN192180B publication Critical patent/IN192180B/en
Priority to ZA200402532A priority patent/ZA200402532B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IN1002DE2001 2001-09-28 2001-09-28 IN192180B (ko)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IN1002DE2001 IN192180B (ko) 2001-09-28 2001-09-28
EP02800214A EP1434568A1 (en) 2001-09-28 2002-09-27 Extended release pharmaceutical composition containing metformin
US10/432,654 US20040059001A1 (en) 2001-09-28 2002-09-27 Extended release pharmaceutical composition containing metformin
JP2003532037A JP2005507896A (ja) 2001-09-28 2002-09-27 メトフォルミン含有放出延長型医薬組成物
EA200400487A EA200400487A1 (ru) 2001-09-28 2002-09-27 Фармацевтическая композиция длительного высвобождения, содержащая метформин
MXPA04002910A MXPA04002910A (es) 2001-09-28 2002-09-27 Composicion farmaceutica de liberacion prolongada que contiene metformin.
CNA02822180XA CN1582145A (zh) 2001-09-28 2002-09-27 含有二甲双胍的缓释药物组合物
BR0212931-0A BR0212931A (pt) 2001-09-28 2002-09-27 Composição farmacêutica de liberação prolongada contendo metformina
KR10-2004-7004586A KR20040063900A (ko) 2001-09-28 2002-09-27 메트포르민을 함유하는 서방 약학 조성물
PCT/IB2002/003997 WO2003028704A1 (en) 2001-09-28 2002-09-27 Extended release pharmaceutical composition containing metformin
ARP020103687A AR037326A1 (es) 2001-09-28 2002-09-30 Composicion farmaceutica de liberacion prolongada que contiene metformina
ZA200402532A ZA200402532B (en) 2001-09-28 2004-03-31 Extended release pharmaceutical composition containing metformin.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1002DE2001 IN192180B (ko) 2001-09-28 2001-09-28

Publications (1)

Publication Number Publication Date
IN192180B true IN192180B (ko) 2004-03-06

Family

ID=11097117

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1002DE2001 IN192180B (ko) 2001-09-28 2001-09-28

Country Status (12)

Country Link
US (1) US20040059001A1 (ko)
EP (1) EP1434568A1 (ko)
JP (1) JP2005507896A (ko)
KR (1) KR20040063900A (ko)
CN (1) CN1582145A (ko)
AR (1) AR037326A1 (ko)
BR (1) BR0212931A (ko)
EA (1) EA200400487A1 (ko)
IN (1) IN192180B (ko)
MX (1) MXPA04002910A (ko)
WO (1) WO2003028704A1 (ko)
ZA (1) ZA200402532B (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1515701B1 (en) * 2002-06-17 2014-09-17 Inventia Healthcare Private Limited Process for the manufacture of multilayer tablet compositions comprising thiazolidinedione and biguanide
WO2004110422A1 (en) * 2003-06-16 2004-12-23 Ranbaxy Laboratories Limited Extended-release tablets of metformin
WO2005092293A1 (en) * 2004-03-22 2005-10-06 Ranbaxy Laboratories Limited Formulations of metformin
WO2006038226A2 (en) * 2004-10-08 2006-04-13 Rubicon Research Pvt. Ltd. Process for making a highly compressible controlled delivery compositions of metformin
UA83152C2 (ru) * 2004-10-19 2008-06-10 Крка, Товарна Здравіл, Д.Д., Ново Мєсто Твердая фармацевтическая композиция, содержащая донепезила гидрохлорид
WO2006082523A2 (en) * 2005-01-25 2006-08-10 Aurobindo Pharma Limited Pharmaceutical sustained release composition of metformin
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
BRPI0608609A2 (pt) * 2005-05-10 2010-01-19 Novartis Ag processo de extrusço para preparaÇço de composiÇÕes com compostos terapÊuticos fracamente compressÍveis
KR100780553B1 (ko) * 2005-08-18 2007-11-29 한올제약주식회사 메트포르민 서방정 및 그의 제조방법
CN101299993A (zh) * 2005-11-04 2008-11-05 伊士曼化工公司 用于给药难溶的药学活性剂的羧烷基纤维素酯
BRPI0605967A (pt) * 2006-12-20 2008-08-12 Medley S A Ind Farmaceutica composição farmacêutica de liberação controlada, forma farmacêutica de liberação controlada e processo para obtenção de forma farmacêutica
WO2008093984A1 (en) 2007-01-29 2008-08-07 Hanall Pharmaceutical Company. Ltd N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
KR101597004B1 (ko) 2013-07-25 2016-02-23 씨제이헬스케어 주식회사 서방형 메트포르민과 속방형 HMG-CoA 환원효소 억제제를 포함하는 복합제제
CN106138020A (zh) * 2015-04-03 2016-11-23 中国人民解放军第三军医大学第三附属医院 双胍类药物在制备预防或减弱肺纤维化的药物中的应用
CN107049980A (zh) * 2017-04-01 2017-08-18 重庆康刻尔制药有限公司 一种盐酸二甲双胍缓释片及其制备方法
KR20210081290A (ko) * 2019-12-23 2021-07-01 주식회사 대웅제약 메트포르민 서방성 제제 및 이의 제조 방법
CN111588701B (zh) * 2020-05-25 2021-04-23 上海普康药业有限公司 一种盐酸二甲双胍缓释片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813064D0 (en) * 1988-06-02 1988-07-06 Euro Celtique Sa Controlled release dosage forms having defined water content
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
DE4432757A1 (de) * 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
EP1039890B1 (en) * 1997-12-08 2004-03-17 Bristol-Myers Squibb Company Novel salts of metformin and method
AP1224A (en) * 1998-03-19 2003-11-14 Bristol Myers Squibb Co Biphasic controlled release delivery system for high solubility pharmaceuticals and method.
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets

Also Published As

Publication number Publication date
WO2003028704A1 (en) 2003-04-10
ZA200402532B (en) 2005-01-04
EA200400487A1 (ru) 2004-10-28
AR037326A1 (es) 2004-11-03
CN1582145A (zh) 2005-02-16
BR0212931A (pt) 2004-10-13
JP2005507896A (ja) 2005-03-24
KR20040063900A (ko) 2004-07-14
MXPA04002910A (es) 2004-07-05
US20040059001A1 (en) 2004-03-25
EP1434568A1 (en) 2004-07-07

Similar Documents

Publication Publication Date Title
BE2022C531I2 (ko)
BE2022C502I2 (ko)
BE2022C547I2 (ko)
BE2017C057I2 (ko)
BE2017C051I2 (ko)
BE2015C046I2 (ko)
BE2014C052I2 (ko)
BE2014C036I2 (ko)
BE2014C026I2 (ko)
BE2014C004I2 (ko)
BE2011C034I2 (ko)
JP2002107023A5 (ko)
JP2002022171A5 (ko)
BE2014C006I2 (ko)
BRPI0209186B1 (ko)
JP2002231952A5 (ko)
JP2002084339A5 (ko)
BE2014C008I2 (ko)
BRPI0204884B1 (ko)
CH1379220H1 (ko)
BE2016C043I2 (ko)
BE2016C021I2 (ko)
BE2017C059I2 (ko)
IN192180B (ko)
BRPI0101486B8 (ko)